Martin Auster, Chief Financial Officer at Ventyx Biosciences, Inc. (VTYX), sold 195,294 shares at $29.01 ($5.7M) on 2022-12-02, disclosed to the SEC on 2022-12-06.
Open-market sale of $5.7M VTYX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.01 | 97,647 | $2.8M | 50.0% |
| 2 | $29.01 | 97,647 | $2.8M | 50.0% |
| Total | $29.01 avg | 195,294 | $5.7M | 100% |
| Filing → |
| VTYX | SELL | 2023-07-26 | $995K | — | Filing → |
| VTYX | SELL | 2023-06-07 | $1.9M | — | Filing → |
| VTYX | SELL | 2023-04-27 | $2.1M | — | Filing → |